SKU: SKU: C1 07007302190
PZN: PZN: 10268778
Roche Diabetes Care Deutschl.GmbH CARDIAC tests for Cobas H232
Verpackungseinheit : 10 tests
type : CARDIAC POC Troponin T-Test (for type HBM4)
Couldn't load pickup availability
CARDIAC T-TEST / CARDIAC POC Troponin T-TEST
-
Application: Supports the early diagnosis of acute myocardial infarction (AMI) and the identification of patients at increased risk of mortality.
-
Biomarker: Troponin T, a protein released into the blood when the heart muscle is damaged.
- Note: Elevated troponin T levels indicate myocardial damage and are a specific marker for myocardial infarction.
CARDIAC M-TEST
-
Application: Early marker of myocardial injury to assist in the diagnosis of acute coronary syndrome and myocardial infarction.
-
Biomarker: Myoglobin, an oxygen-binding protein in muscle tissue that is released when muscles, including the heart muscle, are damaged.
-
Note: Due to its rapid release, myoglobin can serve as an early marker of myocardial damage, but with lower specificity compared to troponin.
CARDIAC D-DIMER TEST
-
Application: Exclusion of deep vein thrombosis and pulmonary embolism.
-
Biomarker: D-dimer, a fibrin degradation product produced during fibrinolysis.
-
Note: Elevated D-dimer levels may indicate thrombotic events, but the test is nonspecific and requires further diagnostic evaluation.
CARDIAC PRO BNP+ TEST
-
Application: Supports diagnosis in patients with suspected heart failure (HF), monitoring of patients with compensated left ventricular dysfunction, and risk stratification of patients with acute coronary syndrome.
-
Biomarker: N-terminal pro-brain natriuretic peptide (NT-proBNP), a hormone released when the heart ventricles stretch.
- Note: Elevated NT-proBNP levels are an indicator of heart failure and correlate with the severity of the disease.
CARDIAC CK-MB TEST
-
Application: Supports the diagnosis of acute coronary syndrome and myocardial infarction, as well as the assessment of reinfarctions.
-
Biomarker: Creatine kinase muscle/brain (CK-MB), an enzyme released when the heart muscle is damaged.
-
Note: CK-MB used to be a standard marker for myocardial infarction, but is increasingly being replaced by more specific markers such as troponin.
- General note: These tests are intended to assist in the diagnosis of cardiovascular disease. The results should always be interpreted in a clinical context and in consultation with the treating physician.
Delivery information: 10 tests
PZN: " 10268778 "
WEEE number:
Assistive device number:
Manufacturer:
Roche Deutschland Holding GmbH
Emil-Barell-Str. 1
79639 Grenzach-Wyhlen
Deutschland
Tel: +49 7624 14 – 0
Email: grenzach.communications@roche.com
VAT ID number: DE197246205
